nodes	percent_of_prediction	percent_of_DWPC	metapath
Clevidipine—BCHE—Cisplatin—urinary bladder cancer	0.172	0.274	CbGbCtD
Clevidipine—CYP3A4—Thiotepa—urinary bladder cancer	0.0949	0.151	CbGbCtD
Clevidipine—CYP2E1—Etoposide—urinary bladder cancer	0.0849	0.135	CbGbCtD
Clevidipine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0589	0.0936	CbGbCtD
Clevidipine—CYP2C9—Fluorouracil—urinary bladder cancer	0.053	0.0843	CbGbCtD
Clevidipine—CYP1A2—Etoposide—urinary bladder cancer	0.0491	0.0781	CbGbCtD
Clevidipine—CYP2C9—Cisplatin—urinary bladder cancer	0.045	0.0716	CbGbCtD
Clevidipine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0276	0.0439	CbGbCtD
Clevidipine—CYP3A4—Etoposide—urinary bladder cancer	0.0257	0.0409	CbGbCtD
Clevidipine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0176	0.0279	CbGbCtD
Clevidipine—CACNA1S—seminal vesicle—urinary bladder cancer	0.0118	0.0883	CbGeAlD
Clevidipine—CYP2C19—urine—urinary bladder cancer	0.0117	0.0881	CbGeAlD
Clevidipine—CYP1A2—urine—urinary bladder cancer	0.00959	0.0719	CbGeAlD
Clevidipine—CYP2C9—urine—urinary bladder cancer	0.0091	0.0683	CbGeAlD
Clevidipine—CYP2E1—urine—urinary bladder cancer	0.00863	0.0647	CbGeAlD
Clevidipine—CACNA1D—prostate gland—urinary bladder cancer	0.00731	0.0548	CbGeAlD
Clevidipine—CYP3A4—urine—urinary bladder cancer	0.00694	0.0521	CbGeAlD
Clevidipine—CYP2D6—urine—urinary bladder cancer	0.00683	0.0512	CbGeAlD
Clevidipine—CACNA1C—prostate gland—urinary bladder cancer	0.00675	0.0506	CbGeAlD
Clevidipine—CACNA1C—smooth muscle tissue—urinary bladder cancer	0.00478	0.0358	CbGeAlD
Clevidipine—BCHE—prostate gland—urinary bladder cancer	0.0037	0.0278	CbGeAlD
Clevidipine—CACNA1C—female reproductive system—urinary bladder cancer	0.00368	0.0276	CbGeAlD
Clevidipine—CACNA1C—vagina—urinary bladder cancer	0.00333	0.025	CbGeAlD
Clevidipine—BCHE—seminal vesicle—urinary bladder cancer	0.00313	0.0235	CbGeAlD
Clevidipine—CYP2E1—prostate gland—urinary bladder cancer	0.0031	0.0232	CbGeAlD
Clevidipine—BCHE—smooth muscle tissue—urinary bladder cancer	0.00262	0.0197	CbGeAlD
Clevidipine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00262	0.0197	CbGeAlD
Clevidipine—CYP1A2—renal system—urinary bladder cancer	0.00235	0.0176	CbGeAlD
Clevidipine—CACNA1D—lymph node—urinary bladder cancer	0.00233	0.0175	CbGeAlD
Clevidipine—CACNA1C—lymph node—urinary bladder cancer	0.00216	0.0162	CbGeAlD
Clevidipine—CYP2E1—renal system—urinary bladder cancer	0.00211	0.0158	CbGeAlD
Clevidipine—CYP2C19—vagina—urinary bladder cancer	0.00208	0.0156	CbGeAlD
Clevidipine—CYP2E1—urethra—urinary bladder cancer	0.00207	0.0156	CbGeAlD
Clevidipine—BCHE—female reproductive system—urinary bladder cancer	0.00202	0.0152	CbGeAlD
Clevidipine—BCHE—vagina—urinary bladder cancer	0.00183	0.0137	CbGeAlD
Clevidipine—CYP2C9—female reproductive system—urinary bladder cancer	0.00178	0.0134	CbGeAlD
Clevidipine—CYP3A4—renal system—urinary bladder cancer	0.0017	0.0127	CbGeAlD
Clevidipine—CYP2E1—female reproductive system—urinary bladder cancer	0.00169	0.0127	CbGeAlD
Clevidipine—CYP2D6—renal system—urinary bladder cancer	0.00167	0.0125	CbGeAlD
Clevidipine—CYP3A4—female reproductive system—urinary bladder cancer	0.00136	0.0102	CbGeAlD
Clevidipine—CYP2D6—female reproductive system—urinary bladder cancer	0.00134	0.01	CbGeAlD
Clevidipine—BCHE—lymph node—urinary bladder cancer	0.00118	0.00887	CbGeAlD
Clevidipine—Ileus—Thiotepa—urinary bladder cancer	0.000739	0.0697	CcSEcCtD
Clevidipine—Vomiting—Valrubicin—urinary bladder cancer	0.000343	0.0323	CcSEcCtD
Clevidipine—Headache—Valrubicin—urinary bladder cancer	0.000337	0.0318	CcSEcCtD
Clevidipine—Dyspnoea—Mitomycin—urinary bladder cancer	0.000331	0.0312	CcSEcCtD
Clevidipine—Renal failure acute—Cisplatin—urinary bladder cancer	0.000323	0.0304	CcSEcCtD
Clevidipine—Nausea—Valrubicin—urinary bladder cancer	0.00032	0.0302	CcSEcCtD
Clevidipine—Ileus—Epirubicin—urinary bladder cancer	0.000298	0.0281	CcSEcCtD
Clevidipine—Ileus—Doxorubicin—urinary bladder cancer	0.000275	0.026	CcSEcCtD
Clevidipine—Acute coronary syndrome—Gemcitabine—urinary bladder cancer	0.000243	0.0229	CcSEcCtD
Clevidipine—Myocardial infarction—Gemcitabine—urinary bladder cancer	0.000241	0.0227	CcSEcCtD
Clevidipine—Acute coronary syndrome—Fluorouracil—urinary bladder cancer	0.000239	0.0225	CcSEcCtD
Clevidipine—Myocardial infarction—Fluorouracil—urinary bladder cancer	0.000237	0.0224	CcSEcCtD
Clevidipine—Vomiting—Mitomycin—urinary bladder cancer	0.000236	0.0222	CcSEcCtD
Clevidipine—Headache—Mitomycin—urinary bladder cancer	0.000233	0.0219	CcSEcCtD
Clevidipine—Acute coronary syndrome—Cisplatin—urinary bladder cancer	0.000226	0.0213	CcSEcCtD
Clevidipine—Myocardial infarction—Cisplatin—urinary bladder cancer	0.000225	0.0212	CcSEcCtD
Clevidipine—Nausea—Mitomycin—urinary bladder cancer	0.00022	0.0208	CcSEcCtD
Clevidipine—Acute coronary syndrome—Etoposide—urinary bladder cancer	0.000207	0.0195	CcSEcCtD
Clevidipine—Myocardial infarction—Etoposide—urinary bladder cancer	0.000206	0.0194	CcSEcCtD
Clevidipine—Tachycardia—Thiotepa—urinary bladder cancer	0.000182	0.0172	CcSEcCtD
Clevidipine—Renal failure acute—Methotrexate—urinary bladder cancer	0.000177	0.0167	CcSEcCtD
Clevidipine—Renal failure acute—Epirubicin—urinary bladder cancer	0.000166	0.0156	CcSEcCtD
Clevidipine—Renal failure acute—Doxorubicin—urinary bladder cancer	0.000153	0.0144	CcSEcCtD
Clevidipine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000151	0.0142	CcSEcCtD
Clevidipine—Hypotension—Gemcitabine—urinary bladder cancer	0.000147	0.0138	CcSEcCtD
Clevidipine—Hypotension—Fluorouracil—urinary bladder cancer	0.000144	0.0136	CcSEcCtD
Clevidipine—Tachycardia—Cisplatin—urinary bladder cancer	0.000143	0.0135	CcSEcCtD
Clevidipine—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00014	0.0132	CcSEcCtD
Clevidipine—Dyspnoea—Fluorouracil—urinary bladder cancer	0.000138	0.013	CcSEcCtD
Clevidipine—Hypersensitivity—Thiotepa—urinary bladder cancer	0.000138	0.013	CcSEcCtD
Clevidipine—Hypotension—Cisplatin—urinary bladder cancer	0.000137	0.0129	CcSEcCtD
Clevidipine—Tachycardia—Etoposide—urinary bladder cancer	0.000131	0.0123	CcSEcCtD
Clevidipine—Dyspnoea—Cisplatin—urinary bladder cancer	0.00013	0.0123	CcSEcCtD
Clevidipine—Hypotension—Etoposide—urinary bladder cancer	0.000125	0.0118	CcSEcCtD
Clevidipine—Dyspnoea—Etoposide—urinary bladder cancer	0.00012	0.0113	CcSEcCtD
Clevidipine—Vomiting—Thiotepa—urinary bladder cancer	0.000119	0.0112	CcSEcCtD
Clevidipine—Headache—Thiotepa—urinary bladder cancer	0.000117	0.011	CcSEcCtD
Clevidipine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000114	0.0107	CcSEcCtD
Clevidipine—Nausea—Thiotepa—urinary bladder cancer	0.000111	0.0105	CcSEcCtD
Clevidipine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	0.00011	0.000486	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—EP300—urinary bladder cancer	0.00011	0.000484	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—TNF—urinary bladder cancer	0.00011	0.000483	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	0.000109	0.000481	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—KRAS—urinary bladder cancer	0.000109	0.00048	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—KRAS—urinary bladder cancer	0.000109	0.000479	CbGpPWpGaD
Clevidipine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000108	0.0102	CcSEcCtD
Clevidipine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	0.000107	0.000472	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—NQO1—urinary bladder cancer	0.000107	0.00047	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—SRC—urinary bladder cancer	0.000107	0.00047	CbGpPWpGaD
Clevidipine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000106	0.000465	CbGpPWpGaD
Clevidipine—CACNA1D—Axon guidance—HRAS—urinary bladder cancer	0.000105	0.000464	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	0.000104	0.000459	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	0.000103	0.000456	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	0.000103	0.000456	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	0.000102	0.000448	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—MMP9—urinary bladder cancer	0.000102	0.000448	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	0.000102	0.000448	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—GSTP1—urinary bladder cancer	0.000101	0.000446	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	0.0001	0.000442	CbGpPWpGaD
Clevidipine—Vomiting—Gemcitabine—urinary bladder cancer	9.98e-05	0.00941	CcSEcCtD
Clevidipine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	9.95e-05	0.000438	CbGpPWpGaD
Clevidipine—Hypersensitivity—Etoposide—urinary bladder cancer	9.88e-05	0.00931	CcSEcCtD
Clevidipine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	9.85e-05	0.000434	CbGpPWpGaD
Clevidipine—Headache—Gemcitabine—urinary bladder cancer	9.84e-05	0.00927	CcSEcCtD
Clevidipine—Vomiting—Fluorouracil—urinary bladder cancer	9.82e-05	0.00925	CcSEcCtD
Clevidipine—BCHE—Metabolism—RRM2—urinary bladder cancer	9.79e-05	0.000431	CbGpPWpGaD
Clevidipine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.71e-05	0.000428	CbGpPWpGaD
Clevidipine—Headache—Fluorouracil—urinary bladder cancer	9.67e-05	0.00912	CcSEcCtD
Clevidipine—CACNA1C—Developmental Biology—EP300—urinary bladder cancer	9.65e-05	0.000425	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	9.52e-05	0.000419	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	9.52e-05	0.000419	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	9.47e-05	0.000417	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	9.44e-05	0.000416	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	9.44e-05	0.000416	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—TYMS—urinary bladder cancer	9.42e-05	0.000415	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—SRC—urinary bladder cancer	9.38e-05	0.000413	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—EGFR—urinary bladder cancer	9.36e-05	0.000412	CbGpPWpGaD
Clevidipine—Nausea—Gemcitabine—urinary bladder cancer	9.33e-05	0.00879	CcSEcCtD
Clevidipine—BCHE—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	9.32e-05	0.00041	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—NCOR1—urinary bladder cancer	9.31e-05	0.00041	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—GSTM1—urinary bladder cancer	9.31e-05	0.00041	CbGpPWpGaD
Clevidipine—Vomiting—Cisplatin—urinary bladder cancer	9.3e-05	0.00877	CcSEcCtD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	9.28e-05	0.000409	CbGpPWpGaD
Clevidipine—CACNA1S—Developmental Biology—HRAS—urinary bladder cancer	9.26e-05	0.000408	CbGpPWpGaD
Clevidipine—CACNA1C—Axon guidance—HRAS—urinary bladder cancer	9.25e-05	0.000407	CbGpPWpGaD
Clevidipine—Nausea—Fluorouracil—urinary bladder cancer	9.17e-05	0.00864	CcSEcCtD
Clevidipine—BCHE—Metabolism—ENO2—urinary bladder cancer	9.07e-05	0.000399	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—HPGDS—urinary bladder cancer	9.07e-05	0.000399	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	9.02e-05	0.000397	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—GPX1—urinary bladder cancer	8.92e-05	0.000393	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—TNF—urinary bladder cancer	8.91e-05	0.000392	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—GSTP1—urinary bladder cancer	8.91e-05	0.000392	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—KRAS—urinary bladder cancer	8.84e-05	0.000389	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—GSTT1—urinary bladder cancer	8.8e-05	0.000387	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—ERCC2—urinary bladder cancer	8.76e-05	0.000386	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	8.71e-05	0.000383	CbGpPWpGaD
Clevidipine—Nausea—Cisplatin—urinary bladder cancer	8.69e-05	0.00819	CcSEcCtD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.66e-05	0.000381	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	8.63e-05	0.00038	CbGpPWpGaD
Clevidipine—Vomiting—Etoposide—urinary bladder cancer	8.52e-05	0.00804	CcSEcCtD
Clevidipine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	8.52e-05	0.000375	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	8.51e-05	0.000375	CbGpPWpGaD
Clevidipine—Headache—Etoposide—urinary bladder cancer	8.4e-05	0.00792	CcSEcCtD
Clevidipine—CACNA1C—Metabolism—TYMS—urinary bladder cancer	8.28e-05	0.000365	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—MTHFR—urinary bladder cancer	8.23e-05	0.000362	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—EGFR—urinary bladder cancer	8.22e-05	0.000362	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—NCOR1—urinary bladder cancer	8.18e-05	0.00036	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—GSTM1—urinary bladder cancer	8.18e-05	0.00036	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	8.13e-05	0.000358	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	8.06e-05	0.000355	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	8.06e-05	0.000355	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	8.05e-05	0.000354	CbGpPWpGaD
Clevidipine—Nausea—Etoposide—urinary bladder cancer	7.96e-05	0.00751	CcSEcCtD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.93e-05	0.000349	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	7.84e-05	0.000345	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	7.84e-05	0.000345	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—GPX1—urinary bladder cancer	7.84e-05	0.000345	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—TNF—urinary bladder cancer	7.83e-05	0.000345	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	7.77e-05	0.000342	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—KRAS—urinary bladder cancer	7.77e-05	0.000342	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—ERCC2—urinary bladder cancer	7.69e-05	0.000339	CbGpPWpGaD
Clevidipine—CACNA1D—Developmental Biology—HRAS—urinary bladder cancer	7.51e-05	0.000331	CbGpPWpGaD
Clevidipine—Hypotension—Methotrexate—urinary bladder cancer	7.5e-05	0.00707	CcSEcCtD
Clevidipine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	7.4e-05	0.000326	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—IGF1—urinary bladder cancer	7.39e-05	0.000325	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	7.38e-05	0.000325	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	7.35e-05	0.000324	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	7.34e-05	0.000323	CbGpPWpGaD
Clevidipine—Tachycardia—Epirubicin—urinary bladder cancer	7.33e-05	0.00691	CcSEcCtD
Clevidipine—BCHE—Metabolism—NQO1—urinary bladder cancer	7.31e-05	0.000322	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—MTHFR—urinary bladder cancer	7.23e-05	0.000318	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	7.21e-05	0.000318	CbGpPWpGaD
Clevidipine—Dyspnoea—Methotrexate—urinary bladder cancer	7.16e-05	0.00675	CcSEcCtD
Clevidipine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	7.15e-05	0.000315	CbGpPWpGaD
Clevidipine—BCHE—Neuronal System—HRAS—urinary bladder cancer	7.14e-05	0.000314	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	7.09e-05	0.000312	CbGpPWpGaD
Clevidipine—Hypotension—Epirubicin—urinary bladder cancer	7.02e-05	0.00662	CcSEcCtD
Clevidipine—Tachycardia—Doxorubicin—urinary bladder cancer	6.79e-05	0.0064	CcSEcCtD
Clevidipine—Dyspnoea—Epirubicin—urinary bladder cancer	6.7e-05	0.00632	CcSEcCtD
Clevidipine—CACNA1D—Metabolism—PPARG—urinary bladder cancer	6.68e-05	0.000294	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	6.64e-05	0.000292	CbGpPWpGaD
Clevidipine—CACNA1C—Developmental Biology—HRAS—urinary bladder cancer	6.6e-05	0.000291	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.57e-05	0.000289	CbGpPWpGaD
Clevidipine—Hypotension—Doxorubicin—urinary bladder cancer	6.5e-05	0.00612	CcSEcCtD
Clevidipine—CACNA1D—Metabolism—CREBBP—urinary bladder cancer	6.41e-05	0.000282	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	6.34e-05	0.000279	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	6.29e-05	0.000277	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	6.27e-05	0.000276	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	6.27e-05	0.000276	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.22e-05	0.000274	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.22e-05	0.000274	CbGpPWpGaD
Clevidipine—Dyspnoea—Doxorubicin—urinary bladder cancer	6.2e-05	0.00584	CcSEcCtD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	6.19e-05	0.000272	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	6.11e-05	0.000269	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—GSTP1—urinary bladder cancer	6.1e-05	0.000268	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.02e-05	0.000265	CbGpPWpGaD
Clevidipine—BCHE—Metabolism of proteins—CXCL8—urinary bladder cancer	5.94e-05	0.000262	CbGpPWpGaD
Clevidipine—Hypersensitivity—Methotrexate—urinary bladder cancer	5.92e-05	0.00558	CcSEcCtD
Clevidipine—BCHE—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.9e-05	0.00026	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	5.88e-05	0.000259	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	5.88e-05	0.000259	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PPARG—urinary bladder cancer	5.87e-05	0.000258	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	5.77e-05	0.000254	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	5.73e-05	0.000253	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	5.72e-05	0.000252	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	5.7e-05	0.000251	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.69e-05	0.000251	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	5.67e-05	0.00025	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—TYMS—urinary bladder cancer	5.67e-05	0.00025	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—CREBBP—urinary bladder cancer	5.63e-05	0.000248	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—GSTM1—urinary bladder cancer	5.6e-05	0.000247	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—NCOR1—urinary bladder cancer	5.6e-05	0.000247	CbGpPWpGaD
Clevidipine—Hypersensitivity—Epirubicin—urinary bladder cancer	5.54e-05	0.00522	CcSEcCtD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	5.49e-05	0.000242	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—GPX1—urinary bladder cancer	5.37e-05	0.000236	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—ERCC2—urinary bladder cancer	5.27e-05	0.000232	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PTGS2—urinary bladder cancer	5.25e-05	0.000231	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	5.22e-05	0.00023	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	5.17e-05	0.000228	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.13e-05	0.000226	CbGpPWpGaD
Clevidipine—Hypersensitivity—Doxorubicin—urinary bladder cancer	5.12e-05	0.00483	CcSEcCtD
Clevidipine—Vomiting—Methotrexate—urinary bladder cancer	5.11e-05	0.00481	CcSEcCtD
Clevidipine—Headache—Methotrexate—urinary bladder cancer	5.03e-05	0.00474	CcSEcCtD
Clevidipine—BCHE—Metabolism—MTHFR—urinary bladder cancer	4.95e-05	0.000218	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.9e-05	0.000216	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	4.9e-05	0.000216	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	4.89e-05	0.000215	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.84e-05	0.000213	CbGpPWpGaD
Clevidipine—Vomiting—Epirubicin—urinary bladder cancer	4.78e-05	0.0045	CcSEcCtD
Clevidipine—Nausea—Methotrexate—urinary bladder cancer	4.77e-05	0.0045	CcSEcCtD
Clevidipine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	4.74e-05	0.000209	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.72e-05	0.000208	CbGpPWpGaD
Clevidipine—Headache—Epirubicin—urinary bladder cancer	4.71e-05	0.00444	CcSEcCtD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.69e-05	0.000207	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PTGS2—urinary bladder cancer	4.61e-05	0.000203	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—PTEN—urinary bladder cancer	4.58e-05	0.000202	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	4.53e-05	0.0002	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	4.53e-05	0.0002	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.51e-05	0.000198	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	4.5e-05	0.000198	CbGpPWpGaD
Clevidipine—Nausea—Epirubicin—urinary bladder cancer	4.46e-05	0.00421	CcSEcCtD
Clevidipine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	4.46e-05	0.000197	CbGpPWpGaD
Clevidipine—Vomiting—Doxorubicin—urinary bladder cancer	4.42e-05	0.00417	CcSEcCtD
Clevidipine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	4.42e-05	0.000195	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	4.4e-05	0.000194	CbGpPWpGaD
Clevidipine—CACNA1D—Metabolism—EP300—urinary bladder cancer	4.37e-05	0.000192	CbGpPWpGaD
Clevidipine—Headache—Doxorubicin—urinary bladder cancer	4.36e-05	0.00411	CcSEcCtD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	4.33e-05	0.000191	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	4.17e-05	0.000184	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	4.17e-05	0.000184	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	4.13e-05	0.000182	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	4.13e-05	0.000182	CbGpPWpGaD
Clevidipine—Nausea—Doxorubicin—urinary bladder cancer	4.13e-05	0.00389	CcSEcCtD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	4.11e-05	0.000181	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	4.04e-05	0.000178	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—PTEN—urinary bladder cancer	4.02e-05	0.000177	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PPARG—urinary bladder cancer	4.02e-05	0.000177	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	4.01e-05	0.000177	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.95e-05	0.000174	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.95e-05	0.000174	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—CREBBP—urinary bladder cancer	3.86e-05	0.00017	CbGpPWpGaD
Clevidipine—CACNA1C—Metabolism—EP300—urinary bladder cancer	3.84e-05	0.000169	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	3.81e-05	0.000168	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.77e-05	0.000166	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	3.67e-05	0.000162	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	3.65e-05	0.000161	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	3.63e-05	0.00016	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	3.63e-05	0.00016	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.55e-05	0.000156	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	3.53e-05	0.000156	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	3.53e-05	0.000156	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.51e-05	0.000155	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	3.48e-05	0.000153	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	3.43e-05	0.000151	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	3.41e-05	0.00015	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.41e-05	0.00015	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.37e-05	0.000149	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	3.36e-05	0.000148	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	3.33e-05	0.000147	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	3.23e-05	0.000142	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	3.21e-05	0.000141	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PTGS2—urinary bladder cancer	3.16e-05	0.000139	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.09e-05	0.000136	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	3.05e-05	0.000134	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.95e-05	0.00013	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.94e-05	0.00013	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.85e-05	0.000125	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.83e-05	0.000125	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.82e-05	0.000124	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.8e-05	0.000123	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.8e-05	0.000123	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.8e-05	0.000123	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.78e-05	0.000122	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.76e-05	0.000122	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—PTEN—urinary bladder cancer	2.75e-05	0.000121	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.73e-05	0.00012	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.73e-05	0.00012	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.69e-05	0.000118	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.68e-05	0.000118	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.64e-05	0.000116	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.63e-05	0.000116	CbGpPWpGaD
Clevidipine—BCHE—Metabolism—EP300—urinary bladder cancer	2.63e-05	0.000116	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.61e-05	0.000115	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2.6e-05	0.000115	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	2.58e-05	0.000114	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	2.58e-05	0.000113	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	2.58e-05	0.000113	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	2.55e-05	0.000112	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	2.55e-05	0.000112	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	2.5e-05	0.00011	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	2.48e-05	0.000109	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	2.47e-05	0.000109	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	2.45e-05	0.000108	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	2.42e-05	0.000107	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.41e-05	0.000106	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	2.4e-05	0.000106	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	2.37e-05	0.000105	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.3e-05	0.000101	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	2.28e-05	0.0001	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	2.26e-05	9.94e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	2.21e-05	9.72e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.2e-05	9.68e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	2.18e-05	9.61e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	2.18e-05	9.61e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	2.09e-05	9.2e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	2.05e-05	9.03e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	2.05e-05	9.01e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	2.01e-05	8.84e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.93e-05	8.49e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.93e-05	8.49e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.85e-05	8.13e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.83e-05	8.07e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.83e-05	8.06e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.78e-05	7.86e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.77e-05	7.81e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.76e-05	7.74e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.7e-05	7.5e-05	CbGpPWpGaD
Clevidipine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.7e-05	7.5e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.68e-05	7.42e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.68e-05	7.42e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.61e-05	7.1e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.58e-05	6.97e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.58e-05	6.95e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.56e-05	6.89e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.5e-05	6.62e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.49e-05	6.55e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.45e-05	6.39e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.44e-05	6.34e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.38e-05	6.06e-05	CbGpPWpGaD
Clevidipine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.31e-05	5.78e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	1.27e-05	5.58e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	1.26e-05	5.53e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	1.23e-05	5.42e-05	CbGpPWpGaD
Clevidipine—CYP2D6—Metabolism—EP300—urinary bladder cancer	1.21e-05	5.32e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.21e-05	5.31e-05	CbGpPWpGaD
Clevidipine—CYP2C9—Metabolism—EP300—urinary bladder cancer	1.2e-05	5.27e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	5.11e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	1.07e-05	4.72e-05	CbGpPWpGaD
Clevidipine—CYP1A2—Metabolism—EP300—urinary bladder cancer	1.02e-05	4.51e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.49e-06	4.18e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.28e-06	3.65e-05	CbGpPWpGaD
Clevidipine—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.9e-06	3.48e-05	CbGpPWpGaD
